ArticlePharmacological reports : PR2026
Drugs associated with retroperitoneal fibrosis: assessment of the 1969-2025 Food and Drug Administration (FDA) pharmacovigilance database.
Sara Baldini et al.PubMed ↗Publisher ↗
No numbers read from the abstract.